Human Metabolome Technologies (TSE:6090) E10: 円11.63 (As of Mar. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

TSE:6090 Human Metabolome Technologies Inc TSE:6090
62 GF Score
Price 円625.00
GF Value 円693.69
Valuation Modestly Undervalued
! 3 Warning Signs
View Full Analysis

What is Human Metabolome Technologies E10?

Human Metabolome Technologies TSE:6090 -3.10% 62 E10 is 円11.63 as of Mar. 2026. GuruFocus rates TSE:6090 with a GF Score™ of 62/100 and a GF Value™ of 円693.69 (Modestly Undervalued). The stock has 3 warning signs investors should review.

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller P/E calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years.

Human Metabolome Technologies's adjusted earnings per share data for the three months ended in Mar. 2026 was 円21.610. Add all the adjusted EPS for the past 10 years together and divide 10 will get our e10, which is 円11.63 for the trailing ten years ended in Mar. 2026.

During the past 12 months, Human Metabolome Technologies's average E10 Growth Rate was 20.80% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the E10 growth rate using E10 data.

As of today (2026-08-26), Human Metabolome Technologies's current stock price is 円625.00. Human Metabolome Technologies's E10 for the quarter that ended in Mar. 2026 was 円11.63. Human Metabolome Technologies's Shiller PE Ratio of today is 53.74.

During the past 13 years, the highest Shiller PE Ratio of Human Metabolome Technologies was 2036.36. The lowest was 49.61. And the median was 150.42.


Human Metabolome Technologies  (TSE:6090) E10 Explanation

If a company grows much fast than inflation, E10 may underestimate the company's earnings power. Shiller PE Ratio can seem to be too high even the actual P/E is low.

For the Shiller P/E, the earnings of the past 10 years are inflation-adjusted and averaged. The result is used for P/E calculation. Since it looks at the average over the last 10 years, the Shiller P/E is also called PE10.

The Shiller P/E was first used by professor Robert Shiller to measure the valuation of the overall market. The same calculation is applied here to individual companies.

Human Metabolome Technologies's Shiller P/E Ratio of today is calculated as

Shiller PE Ratio=Share Price/E10
=625.00/11.63
=53.74

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

During the past 13 years, the highest Shiller P/E Ratio of Human Metabolome Technologies was 2036.36. The lowest was 49.61. And the median was 150.42.


Be Aware

Shiller PE Ratio works better for cyclical companies. It gives you a better idea on the company's real earnings power.


Human Metabolome Technologies E10 Related Terms


Human Metabolome Technologies E10 Historical Data

* Premium members only.

The historical data trend for Human Metabolome Technologies's E10 can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Human Metabolome Technologies E10 Chart

Human Metabolome Technologies Annual Data
Trend Mar16 Mar17 Mar18 Mar19 Jun20 Jun21 Jun22 Jun23 Jun24 Jun25
E10
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.00 0.00 -2.16 2.94 4.84

Human Metabolome Technologies Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26 Jun26
E10 Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 4.84 5.57 8.21 11.63 0.00

TSE:6090 vs TMO, DHR, IDXX: E10 Comparison

For the Diagnostics & Research subindustry, Human Metabolome Technologies's Shiller PE Ratio, along with its competitors' market caps and Shiller PE Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Human Metabolome Technologies Shiller PE Ratio vs Medical Diagnostics & Research Industry

For the Medical Diagnostics & Research industry and Healthcare sector, Human Metabolome Technologies's Shiller PE Ratio distribution charts can be found below:

* The bar in red indicates where Human Metabolome Technologies's Shiller PE Ratio falls into.


TSE:6090
62GF Score
Human Metabolome Technologies Inc TSE:6090
E10 is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Human Metabolome Technologies E10 Calculation

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller P/E calculation. When we calculate the today's Shiller P/E ratio of a stock, we use today's price divided by E10.

What is E10? How do we calculate E10?

E10 is the average of the inflation adjusted earnings of a company over the past 10 years. Let's use an example to explain.

If we want to calculate the E10 of Wal-Mart (WMT) for Dec. 31, 2010, we need to have the inflation data and the earnings from 2001 through 2010.

We adjusted the earnings of 2001 earnings data with the total inflation from 2001 through 2010 to the equivalent earnings in 2010. If the total inflation from 2001 to 2010 is 40%, and Wal-Mart earned $1 a share in 2001, then the 2001's equivalent earnings in 2010 is $1.4 a share. If Wal-Mart earns $1 again in 2002, and the total inflation from 2002 through 2010 is 35%, then the equivalent 2002 earnings in 2010 is $1.35. So on and so forth, you get the equivalent earnings of past 10 years. Then you add them together and divided the sum by 10 to get E10.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.

For example, Human Metabolome Technologies's adjusted earnings per share data for the three months ended in Mar. 2026 was:

Adj_EPS= Earnings per Share (Diluted) /CPI of Mar. 2026 (Change)*Current CPI (Mar. 2026)
=21.61/112.7000*112.7000
=21.610

Current CPI (Mar. 2026) = 112.7000.

Human Metabolome Technologies Quarterly Data

per share eps CPI Adj_EPS
201603 17.066 97.900 19.646
201606 -22.640 98.100 -26.009
201609 -6.140 98.000 -7.061
201612 -1.219 98.400 -1.396
201703 17.861 98.100 20.519
201706 -22.740 98.500 -26.018
201709 -16.460 98.800 -18.776
201712 -10.096 99.400 -11.447
201803 22.292 99.200 25.326
201806 -21.820 99.200 -24.789
201809 -27.600 99.900 -31.136
201812 -26.333 99.700 -29.767
201903 14.162 99.700 16.009
201906 0.000 99.800 0.000
201909 -15.140 100.100 -17.046
201912 -5.120 100.500 -5.742
202003 35.249 100.300 39.607
202006 -23.200 99.900 -26.173
202009 -6.260 99.900 -7.062
202012 5.020 99.300 5.697
202103 17.125 99.900 19.319
202106 -6.020 99.500 -6.819
202109 -8.280 100.100 -9.322
202112 22.200 100.100 24.994
202203 33.710 101.100 37.578
202206 -2.250 101.800 -2.491
202209 -2.980 103.100 -3.257
202212 15.535 104.100 16.818
202303 26.139 104.400 28.217
202306 9.680 105.200 10.370
202309 -6.470 106.200 -6.866
202312 18.467 106.800 19.487
202403 26.627 107.200 27.993
202406 2.480 108.200 2.583
202412 0.000 110.700 0.000
202503 35.780 111.100 36.295
202506 -7.860 111.700 -7.930
202509 -17.100 112.000 -17.207
202512 24.840 113.000 24.774
202603 21.610 112.700 21.610

Add all the adjusted EPS together and divide 10 will get our e10.

Frequently Asked Questions Learn more about E10 →
What does a E10 of 円11.63 mean?
Human Metabolome Technologies (TSE:6090) has a E10 of 円11.63 as of Mar. 2026. E10 represents the company's inflation-adjusted earnings per share over a 10-year period. View historical data on Human Metabolome Technologies and its competitors.
Is Human Metabolome Technologies' E10 too high?
Human Metabolome Technologies' current E10 is 円11.63. Overall, Human Metabolome Technologies has a GF Score™ of 62/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Human Metabolome Technologies' E10 compare to TMO and DHR?
Human Metabolome Technologies' E10 of 円11.63 can be compared against companies in the Medical Diagnostics & Research industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good E10 for a Medical Diagnostics & Research company?
A good E10 depends on the Medical Diagnostics & Research industry context. However, E10 should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high E10 mean?
A high E10 can signal that a stock is expensive relative to its fundamentals. E10 represents the company's inflation-adjusted earnings per share over a 10-year period. View historical data on Human Metabolome Technologies and its competitors. Human Metabolome Technologies's current E10 is 円11.63. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Human Metabolome Technologies stock overvalued right now?
Based on GuruFocus' analysis, Human Metabolome Technologies (TSE:6090) is currently considered Modestly Undervalued. The stock's GF Value™ is 円693.69, compared to a current price of 円625.00 — trading 9.9% below its estimated fair value. The current E10 is 円11.63. Human Metabolome Technologies' overall GF Score™ is 62/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is E10 calculated?
E10 is calculated from a company's financial statements. For Human Metabolome Technologies (TSE:6090), the current E10 is 円11.63 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Human Metabolome Technologies (TSE:6090) Overvalued in 2026?

Based on GuruFocus' analysis, Human Metabolome Technologies stock appears to be undervalued. The current stock price of 円625.00 is trading 9.9% below its estimated GF Value™ of 円693.69. GuruFocus considers Human Metabolome Technologies to be Modestly Undervalued.

Key valuation signals for TSE:6090:

  • E10: 円11.63
  • GF Value™: 円693.69 vs. price of 円625.00 (9.9% below fair value)
  • GF Score™: 62/100 with 3 warning signs

No single metric tells the full story. See the TSE:6090 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Human Metabolome Technologies Business Description

Address Yamagata Prefecture Kakuganji Water 246-2, Tsuruoka, JPN, 997-0052
Human Metabolome Technologies Inc is involved in the search and diagnosis of biomarkers and commercialization in the field of drug development.
62GF Score

Get the complete analysis for TSE:6090

E10 is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

円625.00
Price
円693.69
GF Value